Hagen Cramer

Company: QurAlis Corp.

Job title: Chief Technology Officer

Seminars:

Critical Process Parameters in Oligonucleotide Manufacturing: Strategies for Control During Scale-Up 3:30 pm

• Emphasizing the importance of early identification of Critical Process Parameters  (CPP) to enable effective control strategies that ensure consistent product quality and  compliance • Developing robust and predictive down-scale models to accurately illustrate large scale  manufacturing and minimize risk of unexpected results during scale up • Case studies highlighting the impact of insufficient CPP…Read more

day: Day One PM

Panel Discussion: Lowering the Barrier to Entry for Oligonucleotide Drug Development 1:30 pm

• How can companies in the oligo space collaborate to ease entry for small biotechs • Exploring attempts to lower costs of analytical development and manufacturing and their subsequent impacts • Balancing innovation of analytical methods and technology versus cost- saving practises Read more

day: Day Two PM